Acute splanchnic venous thrombosis: Surgical and medical treatment with special emphasis on new aspects of coagulation disorders

European Journal of Vascular and Endovascular Surgery

Volumn 13, Issue 2, 1997, Pages 227-232

  Geelkerken, R H ^a   Cannegieter, S C ^a   Bouter, H ^a   van Bockel, J H ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN; CARDIOLIPIN ANTIBODY; HEPARIN; PHENPROCOUMON; RANITIDINE; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CLINICAL FEATURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESENTERIC VEIN THROMBOSIS; PRIORITY JOURNAL; SPLANCHNIC BLOOD FLOW;

EID: 0030907425     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-5884(97)80026-3     Document Type: Article

References (34)

1. Sitges-Serra A Mas X Roqueta F Fiqueras J Sanz F Mesenteric infarction: an analysis of 83 patients with prognostic studies in 44 cases undergoing a massive bowel resection Br J Surg 75 1988 544 548
2. Clavien PA Muller C Harder F Treatment of mesenteric infarction Br J Surg 74 1987 500 503
3. Kaleya RN Boley SJ Mesenteric venous thrombosis Najarian JS Delaney Progress in gastrointestinal surgery 1989 Year book medical publishers Chigago 417 425
4. Rhee RY Gloviczki P Mendonca CT Mesenteric venous thrombosis: Still a lethal disease in the 1990s J Vasc Surg 20 1994 688 697
5. Jensen CB Smith GA Clinical study of 51 cases of mesenteric infarction Surgery 40 1956 930 933
6. Abdu RA Zakhour BJ Dallis DJ Mesenteric venous thrombosis-1911 to 1984 Surgery 101 1987 383 388
7. Heard SO Helsmoortel CM Kent J Shahnarian A Fink MP Gastric tonometry in healthy volunteers; effect of ranitidine on calculated intramural pH Critical Care Med 19 1991 271 274
8. Clavien PA Durig M Harder F Venous mesenteric infarction: A particular entity Br J Surg 75 1988 252 255
9. Harward TRS Green D Bergan JJ Mesenteric venous thrombosis J Vasc Surg 9 1989 328 333
10. Boley SJ Kaleya RN Brandt LJ Mesenteric venous thrombosis Surg Clin North Am 72 1992 183 201
11. Matthews J White RR Primary mesenteric venous occlusive disease Am J Surg 122 1971 579 583
12. Polk HC Experimental mesenteric venous occlusion III: Diagnosis and treatment of induced mesenteric venous thrombosis Ann Surg 163 1966 432 438
13. Nelson L Kremen A Experimental occlusion of the superior mesenteric vessels with special reference to the role of intravascular thrombosis and its prevention by heparin Surgery 28 1950 819 828
14. Urabe M Kawasaki H Takasaki K Effect of endothelium removal on the vasoconstrictor response to neuronally released 5-hydroxytryptamine and noradrenaline in the rat isolated mesenteric and femoral arteries Br J Pharmacol 102 1991 85 90
15. Jona J Cummings GM Head HB Recurrent primary mesenteric venous thrombosis JAMA 227 1974 1033 1035
16. Antonsson JB Boyle CC Kruithof KL Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs Am J Physiol 259 1990 G519 G523
17. Hartmann M Montgomerry A Jonsson K Haglund U Tissue oxygenation in hemorrhagic shock measured as transcutaneous oxygen tension, subcutaneous oxygen tension and gastrointestinal intramucosal pH in pigs Critical Care Med 19 1991 205 210
18. Kitchens CS Evolution of our understanding of the pathophysiology of primary mesenteric venous thrombosis Am J Surg 163 1992 346 348
19. Kitchens CS Thrombophilia and thrombosis in unusual sites Colman RW Hirsh J Marder VJ Salzman EW Haemostasis and Thrombosis, basic principles and clinical practice 1994 J.B. Lippincott Company Philadelphia 1255 1273
20. Hughes GRV The antiphospholipid syndrome: ten years on Lancet 342 1993 341 344
21. Housley E Anti phospholipid syndrome Eur J Vasc Endovasc Surg 10 1995 394 395
22. Cappell MS Seibold JR Mesenteric venous thrombosis associated with anticardiolipin antibodies in a patient with systemic lupus erythematosus Am J Gastroenterol 87 1992 520 522
23. Villa P Hernandez MC Lopez-Fernandez MF Batlle J Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects Thromb Haemost 72 1994 209 213
24. Asherson RA A “primary” antiphospholipid syndrome? J Rheumatol 15 1988 1742 1746
25. Alarcon-Segovia D Sanchez-Guerrero J Primary antiphospholipid syndrome J Rheumatol 16 1989 482 488
26. Dahlbäck B Carlsson M Svensson PJ Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1993 1004 1008
27. Bertina RM Koeleman BPC Koster T Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
28. Koster T Rosendaal FR Ronde H de Briët E Vandenbroucke JP Bertina RM Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study Lancet 342 1993 1503 1506
29. Svennson PJ Dahlbäck B Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 520
30. Tait RC Walker ID Perry DJ Prevalence of antithrombin deficiency in the healthy population Br J Haemat 87 1994 106 112
31. Hirsh J Piovella F Pini M Congenital antithrombin III deficiency. Incidence and clinical features Am J Med 87 1989 34S 38S
32. Thaler E Lechner K Antithrombin III deficiency and thromboembolism Clin Haematatology 10 1981 369 390
33. Meer FJM van der Rosendaal FR Vandenbroucke JP Briet E Bleeding complications in oral anticoagulant therapy Arch Intern Med 153 1993 1557 1562
34. Menache D O'Malley JP Schorr JB Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with heriditary antithrombin III deficiency Blood 75 1990 33 39